Your browser doesn't support javascript.
loading
Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancer.
Kolben, Thomas; Augustin, D; Armbrust, R; Kolben, T M; Degenhardt, T; Burgmann, M; Goess, C; Ditsch, N; Kates, R; Harbeck, N; Wuerstlein, R.
Afiliación
  • Kolben T; Breast Center, Department for Gynecology and Obstetrics and Comprehensive Cancer Center of LMU, University Hospital Munich - Grosshadern, Ludwig-Maximilians-University, Marchioninistr. 15, 81377, Munich, Germany. thomas.kolben@med.uni-muenchen.de.
  • Augustin D; Breast Center, Department for Gynecology and Obstetrics, Hospital Deggendorf, Deggendorf, Germany.
  • Armbrust R; Department for Gynecology and Obstetrics, Charité University Hospital Berlin, Berlin, Germany.
  • Kolben TM; Breast Center, Department for Gynecology and Obstetrics and Comprehensive Cancer Center of LMU, University Hospital Munich - Grosshadern, Ludwig-Maximilians-University, Marchioninistr. 15, 81377, Munich, Germany.
  • Degenhardt T; Breast Center, Department for Gynecology and Obstetrics and Comprehensive Cancer Center of LMU, University Hospital Munich - Grosshadern, Ludwig-Maximilians-University, Marchioninistr. 15, 81377, Munich, Germany.
  • Burgmann M; Breast Center, Department for Gynecology and Obstetrics and Comprehensive Cancer Center of LMU, University Hospital Munich - Grosshadern, Ludwig-Maximilians-University, Marchioninistr. 15, 81377, Munich, Germany.
  • Goess C; Breast Center, Department for Gynecology and Obstetrics and Comprehensive Cancer Center of LMU, University Hospital Munich - Grosshadern, Ludwig-Maximilians-University, Marchioninistr. 15, 81377, Munich, Germany.
  • Ditsch N; Breast Center, Department for Gynecology and Obstetrics and Comprehensive Cancer Center of LMU, University Hospital Munich - Grosshadern, Ludwig-Maximilians-University, Marchioninistr. 15, 81377, Munich, Germany.
  • Kates R; REK Consulting, Otterfing, Germany.
  • Harbeck N; Breast Center, Department for Gynecology and Obstetrics and Comprehensive Cancer Center of LMU, University Hospital Munich - Grosshadern, Ludwig-Maximilians-University, Marchioninistr. 15, 81377, Munich, Germany.
  • Wuerstlein R; Breast Center, Department for Gynecology and Obstetrics and Comprehensive Cancer Center of LMU, University Hospital Munich - Grosshadern, Ludwig-Maximilians-University, Marchioninistr. 15, 81377, Munich, Germany.
Breast Cancer Res Treat ; 155(1): 109-15, 2016 Jan.
Article en En | MEDLINE | ID: mdl-26643086
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Activador de Plasminógeno de Tipo Uroquinasa / Inhibidor 1 de Activador Plasminogénico Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2016 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Activador de Plasminógeno de Tipo Uroquinasa / Inhibidor 1 de Activador Plasminogénico Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2016 Tipo del documento: Article País de afiliación: Alemania